Skip to Main Content
Back to News

New Analyst Forecast: $GS Given 'Neutral' Rating

None

We just received data on a new analyst forecast for $GS. Goldman Sachs gave a rating of 'Neutral' for $GS.

$GS Analyst Ratings

Wall Street analysts have issued reports on $GS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cowen & Co. issued a "Buy" rating on 04/23/2025
  • Wells Fargo issued a "Overweight" rating on 04/15/2025
  • Barclays issued a "Overweight" rating on 01/27/2025
  • Morgan Stanley issued a "Overweight" rating on 01/27/2025
  • Evercore ISI issued a "Outperform" rating on 01/02/2025

To track analyst ratings and price targets for $GS, check out Quiver Quantitative's $GS forecast page.

$GS Price Targets

Multiple analysts have issued price targets for $GS recently. We have seen 5 analysts offer price targets for $GS in the last 6 months, with a median target of $625.0.

Here are some recent targets:

  • Gerard Cassidy from RBC Capital set a target price of $560.0 on 04/15/2025
  • Mike Mayo from Wells Fargo set a target price of $650.0 on 04/15/2025
  • Betsy Graseck from Morgan Stanley set a target price of $558.0 on 04/07/2025
  • An analyst from Goldman Sachs set a target price of $625.0 on 03/25/2025

$GS Congressional Stock Trading

Members of Congress have traded $GS stock 18 times in the past 6 months. Of those trades, 14 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $GS stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$GS Insider Trading Activity

$GS insiders have traded $GS stock on the open market 66 times in the past 6 months. Of those trades, 10 have been purchases and 56 have been sales.

Here’s a breakdown of recent trading of $GS stock by insiders over the last 6 months:

  • THOMAS K. MONTAG has made 0 purchases and 17 sales selling 20,000 shares for an estimated $11,899,207.
  • DENIS P. COLEMAN (Chief Financial Officer) sold 12,929 shares for an estimated $7,667,284
  • JOHN F.W. ROGERS (Executive Vice President) has made 0 purchases and 6 sales selling 11,391 shares for an estimated $6,823,219.
  • DAVID M SOLOMON (Chairman of the Board and CEO) has made 0 purchases and 2 sales selling 8,965 shares for an estimated $5,503,952.
  • KATHRYN H. RUEMMLER (Chief Legal Officer, GC) sold 7,498 shares for an estimated $4,758,905
  • ALEX S GOLTEN (CHIEF RISK OFFICER) has made 0 purchases and 2 sales selling 5,208 shares for an estimated $3,313,567.
  • CAREY HALIO (Global Treasurer) has made 0 purchases and 16 sales selling 5,185 shares for an estimated $3,282,853.
  • DAVID A VINIAR sold 5,000 shares for an estimated $3,060,400
  • SHEARA J FREDMAN (Chief Accounting Officer) has made 0 purchases and 10 sales selling 5,008 shares for an estimated $3,043,401.
  • JOHN B HESS has made 9 purchases buying 3,904 shares for an estimated $1,997,583 and 0 sales.
  • KEVIN R JOHNSON purchased 2,400 shares for an estimated $1,485,648

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GS Hedge Fund Activity

We have seen 1,150 institutional investors add shares of $GS stock to their portfolio, and 915 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles